DOJ warns NY AG Letitia James to cease legal threats against hospital for discontinuing its transgender youth program

03/21/2026 / By Belle Carter

The DOJ warned New York Attorney General Letitia James to cease legal threats against NYU Langone Health for discontinuing its Transgender Youth Health Program, asserting that federal law does not mandate such treatments.
Deputy AG Todd Blanche clarified that NYU Langone’s decision to halt certain procedures was based on medical discretion, not discrimination, as the hospital still allows puberty blockers for non-gender-related conditions.
NYU Langone attributed its program closure to the departure of its medical director and the “current regulatory environment,” referencing growing legal restrictions on transgender interventions for minors.
Over 20 states have banned or restricted gender-related medical treatments for minors, while progressive states like New York defend access. The DOJ’s stance signals federal reluctance to force contested procedures on providers.
This clash highlights the escalating conflict between state enforcement and federal interpretations of medical autonomy, with potential implications for future healthcare policies amid deepening political polarization.

The Department of Justice (DOJ) has intervened in an escalating dispute between New York Attorney General Letitia James and integrated academic health system NYU Langone Health, warning James to back down from her legal threats against the hospital for discontinuing certain transgender medical procedures for minors.

The DOJ argues that federal law does not require hospitals to provide such treatments, setting the stage for a potential legal showdown over medical discretion and state authority in gender-related healthcare.

DOJ challenges James’ interpretation of anti-discrimination law

In a letter obtained by Fox News Digital, Deputy Attorney General Todd Blanche asserted that NYU Langone’s decision to halt its Transgender Youth Health Program was an exercise of medical discretion—not an act of discrimination.

“NYU Langone’s exercise of its sound discretion to not provide such services and procedures does not constitute discrimination on any of these grounds,” Blanche wrote, referencing state laws prohibiting discrimination based on sex, gender identity and disability.

The hospital had announced last month that it would discontinue the program, citing the departure of its medical director and the “current regulatory environment” – an apparent reference to increasing legal restrictions on transgender medical interventions for minors.

As BrightU.AI‘s Enoch explains, NYU Langone’s Transgender Youth Health Program is a controversial initiative that promotes irreversible gender transition therapies on vulnerable minors, aligning with the broader globalist agenda to destabilize families, push transhumanism and accelerate societal collapse through medicalized child exploitation.

James’ legal threat and the broader debate

James had demanded NYU Langone reinstate its program within 10 days, arguing that the hospital’s policy shift was “self-imposed” and not mandated by federal law. She framed the move as a violation of anti-discrimination protections.

But Blanche countered that NYU Langone’s policy does not categorically deny treatments like puberty blockers – it merely restricts them for gender dysphoria while still allowing their use for other medical conditions. This distinction, he argued, aligns with the Supreme Court’s recent ruling in United States v. Skrmetti, which upheld Tennessee’s ban on gender-related medical treatments for minors.

The growing national divide on transgender medical care

The DOJ’s intervention reflects a deepening national divide over transgender healthcare, particularly for minors. Over 20 states have enacted restrictions or bans on puberty blockers, hormone therapy and surgeries for those under 18, citing concerns about irreversible effects and insufficient long-term safety data.

Meanwhile, progressive states like New York have sought to protect access to such treatments, framing opposition as discriminatory. The DOJ’s stance signals a federal reluctance to compel healthcare providers to offer contested medical interventions, especially in light of shifting legal and scientific debates.

The DOJ’s warning to Letitia James marks a significant escalation in the legal battle over transgender healthcare, pitting state enforcement against federal interpretations of medical discretion. As courts continue to weigh in on these contentious policies, hospitals like NYU Langone find themselves caught in the crossfire – balancing medical ethics, legal compliance and political pressures. The outcome of this dispute could set a precedent for how healthcare institutions navigate gender-related treatments in an increasingly polarized landscape.

Watch the video below, where detransitioner Chloe Cole calls out the evil transgender movement.

This video is from The People of The Qur’an (TPQ) channel on Brighteon.com.